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There are different opinions about the role of hydrogen sulfide (H2S) in catalytic and energy 
processes, but the biochemistry of all possible effects of H2S is not well studied yet. The en-
zymatic synthesis of H2S is catalyzed by cystathionine-γ-lyase, cystathionine-β-synthase, 
cysteine aminotransferase and in mitochondria by 3-mercaptopyruvate sulfurtransferase only. 
H2S may function as an energy substrate to sustain the ATP synthesis under stress conditions, 
but in high concentration H2S inhibits respiratory complex IV, blocking electron transport and 
proton pumping. The interaction between glucose in high concentrtaion, H2S, and the KATP 
channels may constitute a novel mechanism for the control of insulin secretion. The positive 
effect of H2S on the bioenergetic function of mitochondria may be used in therapy of many 
diseases.
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Introduction
The knowledge of hydrogen sulfide (H2S) as 
a potent signaling molecule greatly advanced 
over the last years, though the biomolecule is 
known from the very beginning of the life 
evolution. H2S is the hydrogenated sulfur com-
pound with the lowest oxidation state (-2). The 
description of gas dates back to the 15th cen-
tury when it was named “hepatic air” [1]. The 
first chemical synthesis was performed by Carl 
Wilhelm Scheele in 1777 by mixing metal 
sulfides with acid, and in 1796 Claude Louis 
Berthollet studied its chemical composition. 
The compound is a flammable, colorless, wa-
ter-soluble gas denser than air [2]. 
There are different opinions about the role 
of H2S in synthetic, catalytic and energy pro-
cesses. The ways of the molecule synthesis in 
mammals were ascertained in the 1940s. In the 
1990s, the data on the modulatory and signa-
ling effects of H2S first appeared. H2S repre-
sents an inorganic reducing substrate for oxida-
tive phosphorylation in mammals [3]. The 
interest in studying H2S was triggered by its 
potential importance for health. The attempt 
to describe the pathways of formation, to de-
termine a biological role, to characterize and 
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explain the physiological effects and to syn-
thesize donors of the biomolecule are promis-
ing for innovation of the effective pharmaco-
logical treatment. H2S has important effects 
on mitochondria. The biomolecule influences 
the mitochondrial electron transport chain. And 
the reactions with metal centers and thiol oxi-
dation products are possible mechanisms of 
these biological effects [4].
Key biochemical questions are the role of 
H2S in the bioenergetic processes and its influ-
ence on the diabetes development and its com-
plications. In this review, we give a short over-
view of the biological role of H2S in mitochon-
dria, the regulation of cellular bioenergetics 
and the influence on diabetes mellitus. 
The enzymology of H2S formation
In mammals, the endogenous H2S is synthe-
sized from homocysteine and cysteine through 
the enzymes of the transsulfuration pathway. 
These enzymes are cystathionine-β-synthase 
(CBS), cystathionine-γ-lyase (CSE), cysteine 
aminotransferase (CAT) and 3-mercaptopyru-
vate sulfurtransferase (3-MST). CBS 
(EC 4.2.1.22), CSE (EC 4.4.1.1) are cytosolic 
enzymes only, whereas CAT (EC 2.6.1.3) and 
3-MST (EC 2.8.1.2) can be present in both 
cytosol and mitochondria [5]. These enzymes 
utilize L-cysteine as a substrate that can be 
taken up with the diet, extracted from endog-
enous proteins, or synthesized endogenously 
via trans-sulfuration of serine by L-methionine 
[6, 7].
3-MST is involved in cyanide detoxification 
as an enzyme that transfers the sulfane sulfur 
from substrate to cyanide ion, giving nontoxic 
thiocyanate and pyruvate. Zink is the cofactor 
of 3-MST. CAT, CBS, and CSE are pyridoxal 
phosphate-dependent enzymes that take part 
in the synthesis of cysteine from methionine 
and serine. CBS and CSE can execute alterna-
tive reactions that yield H2S [5]. The enzyme 
cystathionine-β-synthase catalyzes the replace-
ment of serine with homocysteine forming 
cystathionine and water. If cysteine is used 
instead of serine, the products formed are cys-
tathionine and H2S. CSE catalyzes the elimina-
tion of cystathionine to produce cysteine, a-
ketobutyrate and ammonia. Alternatively, CSE 
can form H2S from both cysteine and, less 
significantly, homocysteine [7, 8]. 
The rhodanese family enzyme 3-MST cata-
lyzes the formation of pyruvate and a persul-
fide from cysteine derived 3-mercaptopyru-
vate. In the availability of thiols, the persulfide 
can extricate hydrogen sulfide, composing an 
alternative source of the compound [9].
Since there is a tissue-specific expression 
of these enzymes, their contribution to the 
production of H2S is different. CBS and 
3-MST are the main sources of H2S in the 
nervous system, whereas CSE dominates in 
cardiovascular tissues and liver [10–13]. One 
of the major organs regulating endogenous 
H2S generation through cystathionine-β-
synthase and cystathionine-γ-lyase is the kid-
ney [14]. And an alternative pathway for H2S 
formation is the reduction of some sulfur-
containing compounds. For instance, cysteine 
persulfide (a product of the reactions of disul-
fides and sulfenic acids with H2S) may be 
synthesized from cystine in the presence of 
CBS or CSE [15, 16]; thiosulfate and gluta-
thione can produce glutathione persulfide in 
the presence of sulfurtransferases [17], and 
cysteine desulfurases can form a protein-
bound persulfide from cysteine. All above 
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persulfides can release H2S in the presence of 
necessary reductants [18, 19].
The role of H2S in the respiratory 
chain 
The catabolic pathway of H2S in mitochondria 
contains mitochondrial inner-membrane-bound 
sulfide quinone reductase (SQR), which fixes 
H2S to sulfite (SO32- ) to produce thiosulfate 
(S2O32-); thiosulfate sulfurtransferase ((TST) 
another name is rhodanese), reducing sulfite 
from thiosulfate by fixating the sulfane sulfur 
on an –SH-containing substrate, for example, 
glutathione, to form a persulfide (R-S-SH) 
species; mitochondrial matrix sulfur dioxygen-
ase, which oxidizes the sulfur atom extracted 
from persulfide, converting it again into sulfite; 
mitochondrial sulfite oxidase, which further 
oxidizes sulfite into sulfate SO42-. H2S causes 
protection from the oxidative stress in part by 
the inner membrane component sulfide qui-
none oxidoreductase, the latter transferring the 
electrons from H2S to the electron transport 
chain and coenzyme Q [19-21]. 
The most effective system to control the 
H2S levels appears to be localized in mitochon-
dria and is evolutionary related to the detoxi-
fication and energy producing systems. The 
fact that the evident tissue formation of H2S 
under aerobic conditions is much lower than 
that under anaerobic conditions supports the 
idea that the main consumption pathways of 
H2S are oxygen-dependent. In mammalian 
cells, H2S is the first inorganic reducing sub-
strate for oxidative phosphorylation [3].
The mitochondrial hydrogen sulfide oxida-
tion pathway includes several enzymes, and 
the first is sulfidequinoneoxidoreductase (SQR) 
localized in the inner mitochondrial mem-
brane. Here, the flavoprotein catalyzes the 
transfer of electrons from hydrogen sulfide to 
coenzyme Q producing an intermediate per-
sulfide species that can transfer the sulfane 
sulfur to a suitable acceptor, possibly glutathi-
one [22, 23]. The sulfane sulfur formed at the 
expense of SQR can be oxidized to sulfite by 
sulfur dioxygenase [24] or transferred to sulfite 
to form thiosulfate by the action of enzymes 
of the rhodanese family [25].
The findings of Bucci M et al. [26] provide 
an evidence that H2S acts as an endogenous 
inhibitor of the phosphodiesterase activity. 
So, H2S is able to increase mitochondrial 
energy metabolism by inhibiting phosphodi-
esterase 2A leading to increased mitochon-
drial cAMP [4, 27]. 
The oxidation of hydrogen sulfide in mito-
chondria is vital in intestinal tissues, in which 
H2S formation by the microbiota is counter-
acted by the protective strategies developed 
by colonocytes. It has been suggested that in 
these cell types the oxidation of H2S can com-
pete with that of organic substrates, and com-
plexes I and II can act in reverse, accepting 
electrons from reduced coenzyme Q so as to 
consume H2S even if cytochrome C oxidase 
is inhibited [28–32].
H2S in high concentrations inhibits com-
plex IV, decreases the rate of electron transport 
and proton pumping [4]. This opposite role as 
inhibitor determines that the mitochondrial 
oxygen consumption first increases at low H2S 
concentrations, but then decreases as the con-
centration of H2S increases. The inhibition of 
the respiratory chain by exposure to H2S is 
associated with toxic effects [33]. It is well-
known that ATP contains high-energy phos-
phate bonds and is produced in mitochondria 
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and the cytosol via glycolysis, substrate-level 
phosphorylation, and oxidative phosphoryla-
tion. And energy is released by hydrolysis of 
the phosphate bond. Many chemoautotrophic 
and photoautotrophic bacteria and certain an-
imals use sulfide as an energy substrate [34].
In the work [35], the vasorelaxant effect of 
H2S is shown in vivo and in vitro. The intra-
venous bolus injection of H2S transiently de-
creased blood pressure of rats. The modula-
tory influence of H2S on KATP channels the 
authors explained by a direct interaction of 
H2S and KATP channel proteins. So, hydrogen 
sulfide may induce the reduction of disulfide 
bonds of the KATP channel protein. In other 
words, H2S may function as an energy sub-
strate to sustain ATP synthesis under stress 
conditions, for example, in hypoxia, it may 
help to produce more ATP [34]. 
For the first time, the authors showed that 
NO appears to be a physiological modulator 
of the endogenous production of H2S by in-
creasing the CSE expression and stimulating 
CSE activity. CBS and CSE can translocate to 
mitochondria under stress conditions, to stim-
ulate mitochondrial H2S and adenosine triphos-
phate production [36–38]. 
Hydrogen sulfide can radically decrease 
metabolic demand, meaning that the metabo-
lism of H2S in mitochondria may serve as a 
means for energy supplementation. The cys-
teine level inside mitochondria is 3 times 
higher than in the cytosol. CSE translocation 
is promoted by the growing level of intracel-
lular calcium levels via the calcium ionophore. 
The translocation of CSE to mitochondria 
metabolizes cysteine, produces H2S inside 
mitochondria, and stimulates the energy pro-
duction [34, 36].
3-MST and its role in the bioenergetic 
process
In mitochondria a source of H2S is mercapto-
pyruvate sulfurtransferase, expressed predom-
inantly in kidney cells, liver cells, cardiac cells, 
proximal tubular epithelium, pericentral hepa-
tocytes, and neuroglial cells [9-13].
The crystal structure of MST reveals a mix-
ture of the product complex containing pyru-
vate and an active site of cysteine persulfide 
(Cys248-SSH), and a nonproductive interme-
diate in which 3-MP is covalently linked via 
a disulfide bond to an active site of cysteine 
[19]. According to study [38], in the crystal 
structure of 3-MST an Asp-His-Ser catalytic 
triadis positioned to activate the nucleophilic 
cysteine residue and participate in general 
acid-base chemistry, whereas the kinetic anal-
ysis shows that thioredoxin is likely to be the 
principal physiological persulfide acceptor for 
mercaptopyruvate sulfurtransferase.
An additional enzymatic reaction that oc-
curs mainly in mitochondria is the conversion 
of 3-mercaptopyruvate to H2S and pyruvate. 
The reaction is catalyzed by 3-MST and needs 
the activity of CAT, which also is known as 
aspartate aminotransferase, converting cysteine 
and -ketoglutarate to glutamate and 3-mercap-
topyruvate. α-cysteine that is not generated in 
mammalian tissues but can be consumed by 
food is converted by α-aminotransferase to 
3-mercaptopyruvate, a substrate for 3-MST [9, 
13, 19].
The role of 3-MST in the regulation of cel-
lular bioenergetics is realized in several ways 
[4, 39]. 3-MP in low concentrations produces 
H2S and stimulates the effect on bioenergetic 
parameters, and this process is suppressed by 
the silencing of 3-MST. A higher activity of 
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3-MST inhibits the cellular bioenergetic an-
swer, and limiting of SQR suppresses both 
basal and 3-MP mediated activation of bioen-
ergetic function as well as the L-cysteine-
mediated stimulation of mitochondrial oxygen 
consumption. Cysteine and α-ketoglutarate 
activate the mitochondrial electron transport, 
and these effects are attenuated by the CAT 
inhibitor aspartate. The 3-MP-derived, 3-MST-
mediated production of H2S donates electrons 
into the mitochondrial electron transport chain 
via SQR at the level of Complex II. The acti-
vating effect of enzyme on bioenergetics de-
creased with oxidative stress. Since 3-MP is 
the substrate for 3-MST, mercaptic acids struc-
turally similar to 3-MP would inhibit the activ-
ity of MST. Incidentally, ketobutyrate, keto-
glutarate, and pyruvate were shown to be un-
competitive inhibitors of 3-MST with respect 
to 3-MP [29, 40–42].
H2S is eliminated following the persulfide 
transfer in these reactions:
MST-SH +3-MP → MST-S-SH + pyruvate
MST-S-SH + R-SH → MST-SH + R-S-SH
R-S-SH + RSH→ R-S-S-R + H2S
Inhibition of mitochondrial Complex 
IV by H2S
Mitochondria is one of the major sources of 
reactive oxygen species (ROS), that causes 
serious damage to tissues, the aging process 
and different diseases. Mitochondrial 
Complex IV is the last enzyme of the electron 
transport chain in the inner mitochondrial 
membrane, and is an essential component of 
aerobic cell respiration and energy generation. 
As the final enzyme in the respiratory chain, 
it receives an electron from each of four cyto-
chrome C molecules, and transfers them to one 
oxygen molecule, converting the latter to two 
molecules of water. The process contributes to 
the generation of transmembrane proton and 
it has been established that H2S in high con-
centrations, binds to Complex IV, thereby in-
hibiting the binding of oxygen [43, 44].
The H2S metabolism occurs in three path-
ways: oxidation, methylation, and reaction 
with cytochrome C and other metalloproteins 
or disulfide-containing proteins. The acute 
toxicity of hydrogen sulfide at the molecular 
level has been attributed to the inhibition of 
cytochrome C oxidase [45].  In [4] the authors 
used the combination of three effects for ex-
plaining the complex mode of inhibition: re-
duction of the cytochrome a3 center, followed 
by a reaction with molecular O2; reduction of 
other centers and ligating the ferrocytochrome 
a3 hem group 
However, at lower H2S concentrations, a 
non-competitive type of inhibition has also 
been supposed (Fig. 1). Once the binding of 
oxygen to Complex IV is inhibited, the inner 
mitochondrial membrane potential is dissi-
pated and aerobic ATP generation is blocked 
[30, 46]. 
 The blocking of Complex IV by sulfide 
includes not only the inhibition of cytochrome 
aa3 but also a ‘false substrate’ pathway in 
which a cysteine radical or copper-cysteine 
complex reacts directly with molecular oxy-
gen. Then the electrons from sulfide follow the 
normal oxidative way to Complex III, cyto-
chrome C, and Complex IV and then to ato mic 
oxygen to form water [4, 47].  
When compared to other substrates of the 
mitochondrial respiratory chain (NADH, 
FADH2, succinate, L-alphaglycerophosphate), 
the yield of sulfide in terms of electrons to be 
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used by the respiratory chain is relatively low: 
two molecules of sulfide are necessary to pro-
vide two electrons. It is expensive in terms of 
oxygen: for the same electron transfer in the 
respiratory Complexes III and IV, sulfide oxi-
dation needs three times more oxygen. And 
when it takes place, the yield of energy per one 
oxygen atom consumed is low in comparison 
with NADH or FADH2 generated by oxidation 
of carbon-containing substrates, so sulfide may 
appear as a poor energy substrate. Therefore, 
although the exact role of this process remains 
to be elucidated, sulfide may serve as an ‘emer-
gency’ substrate, or as a substrate that bal-
ances and can complement the electron-donat-
ing effect of Krebs cycle-derived electron 
donors [33, 48–50].
In mitochondria, H2S acts as a cytoprotec-
tive factor inhibiting the activity of cyto-
chrome oxidase following ischemia/reperfu-
sion, upregulating the level of superoxide 
dismutase, and downregulating the levels of 
ROS. Inhibition of cytochrome oxidase often 
occurs in the absence of high H2S levels in 
tissue [33, 48].
In the work [47], the authors suggest that 
H2S poisons mitochondrial respiratory chain 
by binding to iron of cytochrome C oxygenase, 
but it also helps to reduce mitochondrial dam-
age and provides cytoprotection. H2S also acts 
both as neuroprotector increasing the produc-
tion of glutathione [51] and as a modulator of 
the CSE translocation to mitochondria and the 
supply of the cell with ATP during hypoxia [34, 
Fig. 1. Synthesis of hydrogen sulfide and its role in the mitochondrial respiratory chain
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36, 37]. Because mitochondria play a key role 
in cell death pathways, H2S is involved in 
regulating apoptosis [52, 53]. Downregulation 
of the endogenous H2S/CSE pathway, induced 
by high salt concentration, was involved in 
mitochondrion-related human vascular endo-
thelial cell apoptosis leading to the leakage of 
mitochondrial Cyt-C, which activated 
Caspase-9 and Caspase-3 [51, 54–55]. Not only 
the concentration of H2S directs different mi-
tochondrial outcomes, but it may be also im-
portant where H2S is produced inside the cell. 
The role of H2S in diabetes mellitus 
and other diseases
The biological roles of endogenous H2S are 
multiple and rapidly expanding. Its regulatory 
functions span the nervous system, the regula-
tion of cellular metabolism, the regulation of 
immunological and inflammatory responses, 
and various aspects of cardiovascular homeo-
stasis. The metabolic pathway of H2S and mi-
tochondria take part in different pathological 
processes in the organism, like diabetes mel-
litus, diseases of heart, liver, and kidney [56–
62]. It was experimentally confirmed signifi-
cant effects of H2S production or H2S donors 
in cardiovascular diseases, including heart fail-
ure, ischemic myocardium, atherosclerosis, and 
hypertension [53, 58, 63–65]. The authors [46, 
58] studied the influence of H2S levels on car-
diac mitochondrial content. They found that 
restoring H2S levels with H2S-releasing pro-
drug, SG-1002, in the heart failure increased 
cardiac mitochondrial content, improved mito-
chondrial respiration, and ATP production ef-
ficiency, and as a result improved cardiac func-
tion. The study [66] indicates the involvement 
of H2S in modulation of changes in the perme-
ability of mitochondrial membranes, which 
suggests that H2S plays an important role in the 
development of cardiovascular diseases. 
Others authors reported the changes in 
methabolism of gasotransmitter and a similar 
protective effect of H2S in ischemia reperfu-
sion injury of the kidney [28, 54]. In the review 
[67] the cellular and molecular mechanisms of 
protection by H2S in experimental models of 
chronic kidney disease are discussed.
H2S regulates some proteins involved in 
cellular oxidative stress, which could result in 
a protective effect against aging. It inhibits the 
mitochondrial ROS production and prevents 
activation of the adaptor protein p66Shc [68–
71] and reduces the advanced glycation end 
products toxicity by persulfidating its receptor 
for advanced glycation end products [69]. 
Some studies of diabetic disease show that 
increased extracellular glucose induces mito-
chondrial dysfunction in endothelial cells [34, 
57–59, 70]. This causes the inhibition of cel-
lular bioenergetics through the dysfunction of 
mitochondrial electron transport and the gen-
eration of ATP [68, 71–72]. 
In work [74], the authors studied an impor-
tant mechanism for the fine control of insulin 
secretion from pancreatic β-cells. The study 
demonstrated that an increase in extracellular 
glucose concentration lowers the endogenous 
H2S level. The possible mechanism of interac-
tion among glucose, H2S, and the KATP chan-
nels may constitute a novel mechanism for the 
control of insulin secretion from pancreatic 
β-cells in any pathophysiological conditions. 
The KATP channels are sensitive to the chang-
es in intracellular ATP concentration. Elevation 
of intracellular ATP level leads to closure of 
the KATP channels in many metabolically active 
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cells. In this way, the KATP channel is a cou-
pling factor to link metabolic activity and 
membrane excitability. When circulating glu-
cose level elevates, the glucose influx into 
pancreatic β-cells increases as well as the ATP 
production. Consequential closure of the KATP 
channels on plasma membrane depolarizes the 
membrane and opens the voltage-dependent 
calcium channels.  The final eventuality of this 
chain reaction increased the insulin release due 
to elevated intracellular free calcium.  In the 
study it was determined that the endogenous 
H2S production from INS-1E cells varies in 
vivo conditions, which significantly affects the 
insulin secretion from INS-1E cells. H2S stim-
ulates the KATP channels in INS-1E cells, in-
dependently of the activation of cytosolic sec-
ond messengers, which may underlie H2S-
inhibited insulin secretion from these cells. 
There is a hypothesis [71] that H2S provides 
physiological reducing and antioxidant intra-
cellular environment within the endothelial 
cells, which helps to support normal mitochon-
drial functions. So, ROS from hyperglycemic 
mitochondria directly reacts with and con-
sumes the intracellular H2S, which then in-
duces additional mitochondrial dysfunction, 
possibly by oxidative modification of mito-
chondrial proteins. This positive feed-forward 
cycle may then lead to a mitochondrial dys-
function where molecular oxygen is utilized 
to produce ROS instead of ATP, and where 
mitochondrial efficacy is diminished.  
Noteworthy, some authors [4, 52, 38, 70–
77] reported that H2S exerts protective effects 
against the development of diabetic complica-
tions, at least protecting the mitochondria. The 
level of sulfide is decreased in diabetes, in part 
due to an increase in consumption of sulfide 
by ROS production, which causes the down-
regulation of H2S-producing enzyme in endo-
thelial cells, CSE. The results of the study [78] 
evidence that the CSE-produced hydrogen 
sulfide protects beta-cells from glucotoxicity 
via regulation of expression of the thioredox-
in binding protein-2 levels and thus prevents 
the development of type 2 diabetes.
H2S has a protective effect on endothelial 
cell apoptosis induced by high glucose level 
[52]. This effect was linked to the increased 
superoxide dismutases activity and decreased 
generation of reactive oxygen species and 
level of thiobarbituric acid products, which 
subsequently attenuated the high glucose im-
paired antioxidant activities. Genetic expres-
sion or pharmacological supplementation of 
H2S-producing enzymes in hyperglycaemic 
cells reduces the mitochondrial ROS formation 
[38] and exerts the cytoprotective effect, in-
cluding normalization of mitochondrial bioen-
ergetics (recovery of oxidative phosphoryla-
tion, inhibition of glycolysis) [35, 58]. 
Additionally, sulfide protects against the 
activation of pro-inflammatory signaling path-
ways in endothelial cells with hyperglycemia 
(inflammatory cytokine production and NF-κB 
activation) [79-81], against reduction in matrix 
protein synthesis and remodeling [82–84]. 
However, a specific role of H2S in some dis-
eases remains to be investigated.
Conclusions
In mammals, the endogenous H2S is synthe-
sized from homocysteine and cysteine through 
the enzymes of the transsulfuration pathway. 
These enzymes are cystathionine-β-synthase, 
cystathionine-γ-lyase, cysteine aminotransfer-
ase, and mercaptopyruvate sulfurtransferase. 
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In mitochondria, H2S is produced by mercap-
topyruvate sulfurtransferase. H2S may function 
as the source of electrons to sustain ATP syn-
thesis under stress conditions, but in high con-
centration H2S inhibits Complex IV, blocking 
electron transport and proton pumping.
The interaction between glucose in high 
concentration, H2S and the KATP channel may 
constitute a novel mechanism for the control 
of insulin secretion. The positive impact of H2S 
on bioenergetic function in mitochondria may 
have a therapeutic effect against diabetic com-
plications. The problems discussed and the 
processes of synthesis and regulation of H2S 
enzymes in mitochondria need further investi-
gation in this promising field of research.
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Гідроген сульфід і мітохондрія
І. В. Геруш, Є. О. Ференчук
Існуть різні дані про роль гідроген судьфіду (H2S) в 
каталітичних та енергетичних процесах, але біохіміч-
ні механізми різноманітних ефектів H2S ще недостат-
ньо вивчені. Ферментативний синтез H2S здійснюєть-
ся цистатіонін-γ-ліазою, цистатіонін-β-синтазою, цис-
теїн амінотрансферазою, а в мітохондріях – 3-меркап-
топіруват сульфуртрансферазою. H2S може функціо-
нувати як енергетичний субстрат для підтримки 
синтезу АТФ в умовах стресу, але при високій концен-
трації молекула інгібує комплекс IV, блокуючи пере-
несення електронів. Взаємодія між високим рівнем 
глюкози, сірководнем і KATP-каналами може стати 
новим механізмом контролю секреції інсуліну, а ефект 
H2S на біоенергетичну функцію можна застосовувати 
при ускладненнях багатьох захворювань.
К л юч ов і  с л ов а: гідрогену сульфід, мітохондрії, 
енергетичний обмін.
Сероводород и митохондрия
И. В. Геруш, Е. А. Ференчук
Существуют различные данные о роли сероводорода 
(H2S) в каталитических и энергетических процессах 
организма, но биохимические механизмы всевозмож-
ных эффектов H2S еще недостаточно изучены. 
Ферментативный синтез H2S осуществляется циста-
тионин-γ-лиазой, цистатионин-β-синтазой, цистеин 
аминотрансферазой, а в митохондриях – 3-меркапто-
пируват сульфуртрансферазой. H2S может функцио-
нировать как энергетический субстрат для поддержа-
ния синтеза АТФ в условиях стресса, но в высокой 
концентрации молекула ингибирует комплекс IV, бло-
кируя перенос электронов. Взаимодействие между 
высоким уровнем глюкозы, сероводородом и KATP-
каналом может стать новым механизмом контроля 
секреции инсулина, а эффект H2S на биоэнергетиче-
скую функцию возможно применять при осложнениях 
многих заболеваний.
К л юч е в ы е  с л ов а: сероводород, митохондрия, 
энергетический обмен.
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